Last Posted: Aug 27, 2019
- Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnostics
Z Li et al, Nature Comms, August 26, 2019 - Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers.
Jacobson Richard A et al. Cancers 2019 Aug 11(8) - Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine.
Luchini Claudio et al. Cancers 2019 Aug 11(8) - Potential Applications of Circulating Tumor DNA Technology as a Cancer Diagnostic Tool.
Kunnath Anil P et al. Cureus 2019 Jun 11(6) e4907 - Understanding the Mechanisms of Resistance in EGFR -Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy.
Del Re Marzia et al. International journal of molecular sciences 2019 Aug 20(16) - Circulating microbiota-derived metabolites: a "liquid biopsy?
Aragonès Gemma et al. International journal of obesity (2005) 2019 Aug - Advances in prognostic biomarkers for esophageal cancer.
Yang Wanli et al. Expert review of molecular diagnostics 2019 19(2) 109-119 - Role of liquid biopsies in colorectal cancer.
Wills Beatriz et al. Current problems in cancer 2018 42(6) 593-600 - Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis.
Rodriguez Begona Jimenez et al. Journal of clinical medicine 2019 Aug 8(8) - Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
BR McDonald et al, Science Translational Medicine, August 7, 2019
.png)
No hay comentarios:
Publicar un comentario